PERSONALISING CANCER THERAPIES
Driving a revolution in cancer treatment using clonal neoantigens to develop personalised T cell therapies
More Info +London, UK 7 January 2021 – Achilles Therapeutics (“Achilles” or the “Company”), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat multiple types...
Read More +London, UK 7 January 2021 – Achilles Therapeutics (“Achilles”), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat multiple types of solid tumours...
Read More +Stevenage, UK 7 December 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat multiple types of solid tumours...
Read More +